ThrombosisClinic.com - Resource Room

	Home \| Advisory Board \| Contact \| Help \| Sitemap
	Advanced search



Forgot password
Register here >>




	Content for site developed under the guidance of the TRACK Advisory Council.

You are here: Home / Resource Room /

Publications

New Anticoagulants for Prevention and Treatment of Venous Thromboembolism
In this Update to the American Journal of Medicine, Sarah Spinler, PharmD, discusses the pharmacology of new anticoagulant agents and reviews the evidence for their safety and effectiveness in the prevention of venous thromboembolism.

Diagnosis and Treatment of VTE, DVT, and PE
This American Journal of Medicine Update provides clinicians with a comprehensive up-to-date review of the clinical presentation, diagnostic modalities, and treatment guidelines for low- and intermediate-risk (nonmassive) PE. The update also describes diagnostic measures and current and evolving treatment strategies for DVT, defines massive and submassive PE, discusses risk-stratification tools for patients with submassive PE, and reviews the latest data on the efficacy of thrombolysis in different risk-stratification groups.

Risk Stratification for Venous Thromboembolism in Hospitalized Patients
In this update to the American Journal of Medicine, Judd Hollander, MD, MPH, Professor and Clinical Research Director in the Department of Emergency Medicine at the University of Pennsylvania, reviews the current literature on venous thromboembolism risk and methods to risk-stratify hospitalized patients.

Adjunctive Anticoagulation in Fibrinolysis
A review of recent clinical trials examining the use of anticoagulants in patients with ST-elevation myocardial infarction receiving fibrinolytic agents.

Summary of New Recommendations for the Use of Anticoagulant and Antiplatelet Agents in the 2007 ACC/AHA Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction
In this update to the American Journal of Cardiology, Marc Cohen, MD, FACC, discusses new recommendations for the use of anticoagulant and antiplatelet agents from the ACC/AHA 2007 Guidelines for the Management of Patients With UA/NSTEMI.

Risk Factors for Venous Thromboembolism
In this Update, Joseph A. Caprini reviews multiple factors that place a person at risk for developing VTE and presents a VTE risk assessment scoring system.

Strategies for Pharmacologic Thromboprophylaxis in the Obese Patient
Obesity Update edited by Giselle G. Hamad reviewing the implications of
obesity as a risk factor for VTE, the methodology of risk stratification, and
current pharmacologic strategies for the treatment and prevention of VTE.

Obesity, Bariatric Surgery, and Venous Thromboembolism
In this update, Scott F. Gallagher, MD, discusses the relationship between venous thromboembolism (VTE) and obesity, as well as the risk for VTE associated with bariatric surgery.

Case Vignettes - Atrial Fibrillation
This educational activity consists of 5 cases that illustrate different aspects of the management of patients with atrial fibrillation (AF). These cases are intended to further the understanding of and distinguish between various types of patients who have AF and illustrate the best treatment strategies for each.

Thromboprophylaxis in Arthroscopic Surgery
These case vignettes are intended for health care professionals who treat patients undergoing arthroscopic surgery who may be at risk for venous thromboembolism (VTE).

Thrombosis in Women
This supplement to the second issue of the second volume of Gender Medicine will focus on Thrombosis in Women. Venous thromboembolism (VTE) is a leading cause of death in the United States. Women may have additional risk factors that need to be addressed in VTE risk assessment scores.

Add this site to my Favorites